RNPC3 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, in the CML cells, the on-target DNA substrate is presumably at a relatively low concentration compared with the in vitro conditions and—once the RNP is formed—the time required for the Cas9 RNP to find its cognate target is much longer.